1.
Joshi K, KC AK, Rijal RK, Rai SK, Lammichane G, Yadav RD. Compliance and Visual Outcome Of “Treat-And-Extend” Versus “Pro Re Nata”Dosing of Intravitreal Bevacizumab in Wet Age-Related Macular Degeneration – A Perspective From a Developing Country. Birat J. Health Sci. [Internet]. 2020 Jun. 26 [cited 2024 Oct. 15];5(1):921-6. Available from: https://www.nepjol.info/index.php/bjhs/article/view/29614